Lutetium-177 DotaTate Therapy for Neuroendocrine Tumours
Lutetium Dotatate Therapy involves the use of a radioactive isotope, lutetium-177, coupled with a molecule called Dotatate. Dotatate specifically binds to somatostatin receptors found on neuroendocrine tumour (NET) cells.